The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region

Abstract The European sero-epidemiology network (ESEN2) aims to standardise serological surveillance of varicella zoster virus (VZV) in 11 participant countries. In each country, serum banks were collected between 1996 and 2003 and tested for VZV antibodies. Assay results were standardised so that i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2007-11, Vol.25 (45), p.7866-7872
Hauptverfasser: Nardone, A, de Ory, F, Carton, M, Cohen, D, van Damme, P, Davidkin, I, Rota, M.C, de Melker, H, Mossong, J, Slacikova, M, Tischer, A, Andrews, N, Berbers, G, Gabutti, G, Gay, N, Jones, L, Jokinen, S, Kafatos, G, de Aragón, M.V. Martínez, Schneider, F, Smetana, Z, Vargova, B, Vranckx, R, Miller, E
Format: Artikel
Sprache:eng
Schlagworte:
Age
Allergy and Immunology
Antibodies, Viral - analysis
Antigens, Viral - analysis
Banks
Biological and medical sciences
Disease
Enzymes
Epidemiology
Europe - epidemiology
European Continental Ancestry Group
Fundamental and applied biological sciences. Psychology
Herd immunity
Herpes Zoster - epidemiology
Herpes Zoster - prevention & control
Herpesvirus 3, Human - immunology
Humans
Immunization - utilization
Immunoassay
Infections
Italy
Laboratories
Microbiology
Miscellaneous
Mortality
Netherlands
Population
Seroepidemiologic Studies
Seroepidemiology
Vaccination
Vaccines
Varicella zoster virus
Virology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract The European sero-epidemiology network (ESEN2) aims to standardise serological surveillance of varicella zoster virus (VZV) in 11 participant countries. In each country, serum banks were collected between 1996 and 2003 and tested for VZV antibodies. Assay results were standardised so that international comparisons could be made. Age-specific forces of infection were calculated for three age groups (
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2007.07.036